By Sheila Lynch-Afryl, J.D., M.A.
Federal courts’ authority to universally vacate agency rules under the Administrative Procedure Act and state laws applying to drug manufacturers are among the pending issues.
Although the Supreme Court's health law docket has been relatively q ...